Affichage 1 à 2 des 2 essais cliniques
|
ESSAI CLINIQUE No essai ClinicalTrials.gov ID |
Investigateur(trice) principal(e)
Coordonnateur(rice) |
||
|---|---|---|---|
|
(EN) A Phase 2 Study of Blinatumomab in Combination With Nivolumab, a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged ? 1 to < 31 Years Old With First Relapse
COG-AALL1821 NCT04546399  Actif en recrutement
|
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE
|
Leucémie lymphoide aiguë (LLA) |
Dr Yvan Samson |
|
(EN) Phase 3 Randomized, Controlled Study of Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia With Safety Run-in
(Golden Gate Study) NCT04994717 Actif en recrutement
|
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL
PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX
|
Leucémie lymphoide aiguë (LLA) |
Dre Julie Bergeron Julie Trinh Lu 514-252-3400 poste 3336 Michel-Olivier Gratton 514-252-3400 poste 2397 |
Groupe d'étude en oncologie du Québec